|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel显示文摘 | Briggs KE Gokhale PC | 1998 | Int J Oncol1998，12，5： | 1 |
| 2 | Safety and efficacy of liposomal amphotericin B in patients with cryptococcal meningitis 显示文摘 | Kotwani RN Gokhale PC Bodhe PV | 2001 | J Assoc Physicians India2001，49，： | 1 |
| 3 | Comparative in vivo studies with paclitaxol and liposome-encapsulated paclitaxel显示文摘 | Cabanes A Briggs KE Gokhale PC | 1998 | Int J Oncol1998，12，5： | 1 |
| 4 | Comparative in vivo studies with paclitaxel and liposome encapsulated paclitaxel显示文摘 | Cabanes A Briggs KE Gokhale PC | 1998 | Int J Oncol1998，12，5： | 1 |
| 5 | Preclinical characterization of 0SI-027, a potent and selective inhibitor of mTORC1 and mTORC2 : distinct from rapamycin显示文摘 | Bhagwat SV Gokhale PC Crew AP | 2011 | Mol Cancer Ther2011，10，： | 1 |
| 6 | Combination with lipo- some-entrapped, ends-modified raf antisense oligonucleotide (LErafAON) improves the anti-tumor efficacies of cisplatin, epi- rubicin, mitoxantrone, docetaxel and gemcitabine显示文摘 | PEI J ZHANG C GOKHALE PC | 2004 | Anticancer Drugs2004，15，3： | 1 |
| 7 | Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel显示文摘 | Cabanes A Briggs KE Gokhale PC Treat JA Rahman A | 1998 | Int J Oncol1998，12，： | 1 |
| 8 | 两性霉素B脂质体在病人中的药代动力学及耐受性显示文摘机会致病真菌感染,是免疫受损(imm-unocompromised)病人发病和死亡原因之一。患血癌病人,感染真菌的发病率在20%~40%之间,病死率则大于70%。自1958年推荐两性霉素B以来,至今仍保持它作为治疗严重真菌感染首选药物,尽管治疗中出现急慢性毒副反应,时常须更改或中断治疗。目前正研究用脂质体两性霉素B,作为新型设计的释放系统,以图达到避免毒副反应和发挥更好的抗真菌效果。1982年以来,GraybilTaylor Lopez-Berestein、Sculier。 | Gokhale PC 马慕良 | 1994 | 国外医药(抗生素分册)1994，15，4： | 1 |
| 9 | Pituitary adenoma: correlation of half - dose gadolinium - enhanced MR imaging with surgical findings in 26 patients显示文摘 | Davis PC Gokhale KA Joseph GJ | 1991 | Radiology1991，180，： | 1 |
| 10 | Expression of BRCC3,a novel cell cycle regulated molecule,is associated with increased phospho-ERK and cell proliferation显示文摘 | Boudreau HE Broustas CG Gokhale PC | 2007 | Int J Mol Med2007，19，1： | 1 |
| 11 | Antisense raf oligodeoxyribonucleotide is a radiosensitizer in vivo 显示文摘 | Gokhale PC McRae D Monia BP | 1999 | Antisense Nucleic Acid Drug Dev1999，9，2： | 1 |
| 12 | Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin显示文摘 | BHAGWAT S GOKHALE PC CREW AP | 2011 | Mol Cancer Ther2011，10，8： | 1 |
| 13 | Reduced VEGF pro- duction, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibi- tors显示文摘 | Falcon BL Barr S Gokhale PC | 2011 | Cancer Res2011，71，5： | 1 |
| 14 | Comparative in vivo studies with paclitaxel and liposome encapsulated paclitaxei显示文摘 | Cabanes A Briggs KE Gokhale PC | 1998 | Int J Oncol1998，12，： | 1 |
| 15 | Pituitary adenoma: correlation of half-dose gadolinium-enhanced MR imaging with surgical findings in 26 patients 显示文摘 | Davis PC Gokhale KA Joseph GJ | 1991 | Radiology1991，180，3： | 1 |
| 16 | Comparativein rive studies with paclitaxel and liposome-encapsulatedpaclitaxel 显示文摘 | Cabanes A Briggs KE Gokhale PC | 1998 | Int J Oncol1998，12，5： | 1 |
| 17 | Pharmacokinetics,toxicity,and efficacy of ends-modified raf antisense oltgodeoxyribonucleotide encapsulated in a novel cationic liposome显示文摘 | Gokhale PC Zhang C Newsome JT | 2002 | Clin Cancer Res2002，8，11： | 1 |
| 18 | Improved safety, pha- rmacokinetics and therapeutic efficacy profiles of a novel lipo- somal formulation of mitoxantrone 显示文摘 | Gokhale PC Pei J Zhang C | 2001 | Anti cancer Res2001，21，5： | 1 |
| 19 | Comparative in vivo studies with paclitaxel and liposome encapsulated paclitaxel显示文摘 | Cabanes A Briggs KE Gokhale PC | 1998 | Int J Oncol1998，12，： | 1 |
| 20 | Comparativein rive studies with paclitaxel and liposome-encapsulatedpaclitaxel 显示文摘 | Cabanes A Briggs KE Gokhale PC | 1998 | Int J Oncol1998，12，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员